Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Aug 27 2020

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-27-2020-6

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 27, 2020, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases